Study of inflammatory markers at the preclinical stage of Huntington’s disease
DOI:
https://doi.org/10.25557/2310-0435.2022.03.61-62Keywords:
NeuroimmunopathologyAbstract
Conference abstract
Downloads
Published
2022-10-13
Issue
Section
Brief reports
How to Cite
1.
Androsova LV, Ponomareva NV, Simonov AN, Klyushnikov SA, Otman IN, Klyushnik TP. Study of inflammatory markers at the preclinical stage of Huntington’s disease. Патогенез. 2022;20(3):61-62. doi:10.25557/2310-0435.2022.03.61-62